所有图片(3)
About This Item
线性分子式:
MgSO4 · 7H2O
CAS号:
分子量:
246.47
EC號碼:
MDL號碼:
分類程式碼代碼:
12352302
eCl@ss:
38030409
PubChem物質ID:
NACRES:
NA.21
化驗:
≥99.0%
形狀:
powder or crystals
推荐产品
蒸汽密度
<0.01 (vs air)
品質等級
蒸汽壓力
<0.1 mmHg ( 20 °C)
產品線
ReagentPlus®
化驗
≥99.0%
形狀
powder or crystals
pH值
5-8 (50 g/L)
SMILES 字串
O.O.O.O.O.O.O.[Mg++].[O-]S([O-])(=O)=O
InChI
1S/Mg.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2
InChI 密鑰
WRUGWIBCXHJTDG-UHFFFAOYSA-L
正在寻找类似产品? 访问 产品对比指南
一般說明
硫酸镁七水合物是硫酸镁的水合盐。它在无水状态下具有吸湿性。它可以用作亲水性添加剂和有机合成中的催化剂。
應用
七水合硫酸镁可用于：
- 作为室温下邻苯二胺和1,2-二羰基化合物缩合反应的有效催化剂。
- 作为催化剂，广泛用于芳香族醛、苯、脂肪族和芳香族伯胺及乙酸铵合成三/四取代咪唑。
- 通过与十水硼酸钠相互作用制备不同组成的无定形硼酸镁。
七水合硫酸镁可用作催化剂，用于使邻苯二胺与1,2-二羰基化合物缩合形成吩嗪和喹喔啉衍生物。它也可与三氟甲磺酸铟 (Ⅲ) 一起用作催化剂，用于合成三/四取代咪唑。
法律資訊
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
13 - Non Combustible Solids
水污染物質分類（WGK）
WGK 1
閃點（°F）
Not applicable
閃點（°C）
Not applicable
其他客户在看
New conditions for the effective synthesis of tri and tetrasubstituted imidazoles catalysed by recyclable indium (III) triflate and magnesium sulfate heptahydrate.
Karami B, et al.
J. Chem. Res. (M), 38(1), 41-45 (2014)
A facile synthesis of phenazine and quinoxaline (new 1,4-benzo diazine) derivatives using magnesium sulfate heptahydrate as a catalyst.
Karami B and Khodabakhshi S.
J. Serb. Chem. Soc., 76(9), 1191-1198 (2011)
Size-dependent growth of magnesium sulfate heptahydrate.
Rousseau RW and Parks RM.
Industrial & Engineering Chemistry Fundamentals, 20(1), 71-76 (1981)
Ran D Goldman et al.
Pediatrics, 132(6), e1634-e1641 (2013-11-28)
Vaso-occlusive episodes (VOEs) are the most common complication of sickle cell disease in children. Treatment with magnesium seems to improve cellular hydration and may result in reduced vaso-occlusion. This study aimed to determine if intravenous (IV) magnesium sulfate (MgSO4) reduces
Karen J Gibbins et al.
Obstetrics and gynecology, 121(2 Pt 1), 235-240 (2013-01-25)
Clinical trials support the efficacy and safety of magnesium sulfate for cerebral palsy prevention. We evaluated the implementation of a clinical protocol for the use of magnesium for cerebral palsy prevention in our large women's hospital, focusing on uptake, indications
实验方案
Objective: To standardize a procedure to determine the enzymatic activity of Luciferase and/or to determine the ATP detection limit of Luciferase.
Objective: To standardize a procedure for determining the enzymatic activity of 5’-Nucleotidase.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门